US Senate votes overwhelmingly in favor of Montenegro’s accession to NATOWorld March 29, 5:24
Putin’s popularity in Russia ‘unfaltering’ — GallupRussian Politics & Diplomacy March 29, 5:19
Lavrov says he plays football once a week, goes rafting every yearSport March 29, 3:59
UK prime minister signs formal Brexit letter to Brussels — official photoWorld March 29, 1:26
Some 20 Topol-M, Yars mobile ICBM systems take part in massive Central Russian drillsMilitary & Defense March 28, 23:10
Russia clinches last-minute 3-3 draw with Belgium in friendly football match in SochiSport March 28, 21:40
Washington-based National Symphony Orchestra members excited to perform in RussiaSociety & Culture March 28, 21:36
'Gentlefan' continues: 'Angels' greet Belgium football fans ahead of Sochi gameSport March 28, 21:12
Scottish parliament backs new referendum on independenceWorld March 28, 20:42
MOSCOW, May 27. /TASS/. Doping test result of Russian heavyweight boxer Alexander Povetkin, who Sample B tested positive for banned substance meldonium, was not unexpected news and his team was ready for it, Andrei Ryabinsky, the head of the Boxing World promotion company told TASS on Friday.
"It was expected," Ryabinsky said in an interview with TASS. "We never denied that it [meldonium] was there [in Povetkin’s blood]."
WBC Heavyweight Champion Deontay Wilder of the United States (W36-L0, 35 KOs) was scheduled to hold his mandatory title bout against Povetkin (30-1, 22 KOs) on May 21 in Moscow, However, Russian boxer’s doping Sample A had tested positive for meldonium shortly before the fight and the bout was suspended indefinitely.
"This story is about the low concentration of detected meldonium," Ryabinsky said. "However, nobody ever denied that it was present in the [doping] samples."
The found drug in the body system of the 36-year-old Russian fighter was in low concentration of 0.07 micrograms. US sports channel ESPN later reported that before the positive doping result, Povetkin passed doping tests three times, namely on April, 7,8 and 11, and all his samples tested negative. However, his doping test as of April 27 gave a positive indication for meldonium presence in his blood.
Wilder’s management announced earlier it intended to demand from the Russian side a financial compensation of $4.6 million in case the bout was eventually cancelled.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
However, on April 13, WADA announced that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.